Viewing Study NCT06625359


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2025-12-24 @ 3:05 PM
Study NCT ID: NCT06625359
Status: TERMINATED
Last Update Posted: 2024-10-03
First Post: 2024-09-30
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma
Sponsor: Seoul National University Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-06-01
Start Date Type: ACTUAL
Primary Completion Date: 2024-09-30
Primary Completion Date Type: ACTUAL
Completion Date: 2024-09-30
Completion Date Type: ACTUAL
First Submit Date: 2024-09-30
First Submit QC Date: None
Study First Post Date: 2024-10-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-01
Last Update Post Date: 2024-10-03
Last Update Post Date Type: ACTUAL